FP7H2020HORIZON
Novo Nordisk A/S
- Country
- DKDenmark
- Defence projects
- 0
- Projects, all programmes
- 57
- As coordinator
- 1
- EU contribution (CORDIS)
- EUR 4,672,337
- Active
- 2008 to 2025
Projects
57 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| DIRECTDIabetes REsearCh on patient sTratification | FP7 | 2012 | Participant | Not stated |
| ABIRISKAnti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk | FP7 | 2012 | Participant | Not stated |
| COMPACTCollaboration on the Optimisation of Macromolecular Pharmaceutical Access to Cellular Targets | FP7 | 2012 | Participant | Not stated |
| PCDIABA Portable bihormonal Closed Loop for Diabetes | FP7 | 2012 | Participant | EUR 6,647 |
| STEMBANCCStem cells for Biological Assays of Novel drugs and prediCtive toxiCology (StemBANCC) | FP7 | 2012 | Participant | Not stated |
| DDMOREDrug Disease Model Resources | FP7 | 2011 | Participant | Not stated |
| BTCUREBeTheCuRE | FP7 | 2011 | Participant | Not stated |
| IMIDIAImproving beta-cell function and identification of diagnostic biomarkers for treatment monitoring in diabetes | FP7 | 2010 | Participant | Not stated |
| SAFESCIMETEuropean Modular Education and Training Programme in Safety Sciences for Medicines | FP7 | 2010 | Participant | Not stated |
| IC2Intelligent and Customized Tooling | FP7 | 2010 | Participant | Not stated |
| EMTRAINEuropean Medicines Research Training Network | FP7 | 2009 | Participant | Not stated |
| EU2PEuropean programme in Pharmacovigilance and Pharmacoepidemiology | FP7 | 2009 | Participant | Not stated |
| VIBRANTIn Vivo Imaging of Beta cell Receptors by Applied Nano Technology | FP7 | 2009 | Participant | EUR 61,570 |
| PHARMATRAINPharmaceutical Medicine Training Programme | FP7 | 2009 | Participant | Not stated |
| PROTECTPharmacoepidemiolocal Research on Outcomes of Therapeutics by a European ConsorTium | FP7 | 2009 | Participant | Not stated |
| DIAdvisorPersonal Glucose Predictive Diabetes Advisor | FP7 | 2008 | Coordinator | EUR 1,252,786 |
| METAHITMetagenomics of the Human Intestinal Tract | FP7 | 2008 | Participant | EUR 295,000 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.